Concord Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6K Buy
+87
New +$32.3K ﹤0.01% 417
2026
Q1
Sell
-51
Closed -$17.9K 357
2025
Q4
$17.9K Sell
51
-71
-58% -$24K ﹤0.01% 459
2025
Q3
$39.4K Sell
122
-482
-80% -$150K 0.01% 371
2025
Q2
$235K Buy
604
+199
+49% +$80K 0.03% 187
2025
Q1
$176K Sell
405
-1,983
-83% -$796K 0.03% 196
2024
Q4
$881K Sell
2,388
-57
-2% -$23.9K 0.14% 110
2024
Q3
$1.27M Buy
2,445
+208
+9% +$111K 0.21% 83
2024
Q2
$1.21M Sell
2,237
-118
-5% -$62.4K 0.21% 92
2024
Q1
$1.22M Buy
2,355
+561
+31% +$279K 0.22% 90
2023
Q4
$846K Buy
1,794
+1,083
+152% +$501K 0.17% 100
2023
Q3
$310K Sell
711
-369
-34% -$167K 0.07% 150
2023
Q2
$480K Buy
1,080
+201
+23% +$92.7K 0.1% 114
2023
Q1
$404K Buy
879
+160
+22% +$76.1K 0.11% 95
2022
Q4
$369K Sell
719
-154
-18% -$78.2K 0.11% 111
2022
Q3
$396K Sell
873
-43
-5% -$20.6K 0.13% 108
2022
Q2
$442K Buy
916
+76
+9% +$37.6K 0.12% 113
2022
Q1
$413K Buy
840
+9
+1% +$4.11K 0.11% 116
2021
Q4
$385K Buy
831
+105
+14% +$44.2K 0.09% 119
2021
Q3
$271K Sell
726
-76
-9% -$28.9K 0.11% 68
2021
Q2
$306K Buy
802
+38
+5% +$14.5K 0.09% 97
2021
Q1
$274K Sell
764
-248
-25% -$79.8K 0.09% 102
2020
Q4
$325K Buy
+1,012
New +$311K 0.25% 53

Other funds holding ELV

Concord Wealth Partners's ELV Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Elevance Health (ELV) in Q2 2026: 87 shares worth $33.6K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in ELV as recently as Q4 2025.

Concord Wealth Partners first reported a position in ELV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.27M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Concord Wealth Partners held 87 shares of Elevance Health worth $33.6K as of Q2 2026.
  • Elevance Health was a new Concord Wealth Partners position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #417 holding.
  • Concord Wealth Partners first reported a position in Elevance Health in Q4 2020 and has held it in 22 quarters since.
  • Concord Wealth Partners's Elevance Health position peaked at $1.27M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.